Different effects of low-dose transdermal and oral oestrogen therapy on procarboxy-peptidase U, an inhibitor of fibrinolysis, in healthy postmenopausal women: a randomised, placebo-controlled study.

Thromb Haemost

Published: March 2005

Download full-text PDF	Source

Publication Analysis

effects low-dose

low-dose transdermal

transdermal oral

oral oestrogen

oestrogen therapy

therapy procarboxy-peptidase

procarboxy-peptidase inhibitor

inhibitor fibrinolysis

fibrinolysis healthy

healthy postmenopausal

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!